- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06305923
The Efficacy of a Cosmetic Preparation Containing Sheep Colostrum on Mature Skin (COLMATSKIN)
The goal of this clinical trial is to learn about colostrum as a cosmetic in mature skin. . The aim of the study was to examine the effect of a cosmetic preparation containing sheep colostrum on skin with signs of aging in mature women Participants will be given the creams and asked to apply one -two doses in the evening after nighttime facial cleaning. They were also asked to use sunscreens during the day. During the first visit and after eight weeks of everyday use of the tested cream, the skin parameters will be measured three times on both cheeks, and the results were averaged.
Participants will be enrolled to the colostrum cream or base cream groups and will not be informed which group they belonged to.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be enrolled to the colostrum cream or base cream groups and will not be informed which group they belonged to.
Participants will be given the creams and will be asked to apply one -two doses in the evening after nighttime facial cleaning. They will be also asked to use sunscreens during the day.
Instrumental Measurements of Skin Parameters During the first visit and after eight weeks of everyday use of the tested cream, the skin parameters will be measured three times on both cheeks, and the results will be averaged.
The skin will be measured at standardized temperature and humidity using a Courage + Khazaka electronic GmbH Multi Probe Adapter with the use of the following probes:
- Corneometer® CM825 probe: measuring skin hydration based on water content in the stratum corneum;
- Tewameter® TM probe: assessing transepidermal water loss;
- Mexameter® MX18 probe: measuring the level of hemoglobin (erythema) and mel-anin, the two main dyes responsible for skin color;
- Sebumeter® SM 815 probe: measuring skin sebum level, independent of water con-tent;
- Cutometer® MPA 580 probe: measuring the viscoelastic properties of the skin. The R0 and F0 parameters were chosen. R0 represents the passive response of the skin to force, lower values indicate greater firmness. F0 - firmness of the skin at the time of suction. Lower values indicate more elastic skin.
- Photodocumentation The skin will be subjected to photodocumentation at the first and last visit with the use of the Photomedicus system. The photos will be taken in standard light and with stand-ardized face positions. The photos will be compared using the following scale: 0 means no improvement (the same as the initial picture), 1 - slight improvement, 2 - moderate improvement, 3 - marked improvement (marked improvement in appearance from the initial condition, but not completely optimal), 4 - greatest possible improvement (optimal aesthetic result).
- Subjective assessment of the skin All participants, i.e. in both groups, subjectively will assess their skin condition after eight weeks of treatment. Participants will rate smoothing of shallow wrinkles, skin tone alignment, regeneration, hydration, elasticity, softness, redness reduction and hypersen-sitivity reduction; they will indicate either improvement, deterioration or no change. Finally, the results in each group will be presented as the percentage of subjects with improved, worsened or unchanged skin.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lodz, Poland, 90-419
- Medical University of Lodz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Signs of skin aging: wrinkles, loss of skin elasticity, discolorations, dryness
- Signed informed consent
Exclusion Criteria:
- Pregnant or breastfeeding
- Allergic to milk proteins
- Suffer from neoplasms, contagious infections, autoimmunologic diseases
- Suffer from face skin diseases
- Have had an aesthetic procedure on the skin of the face during the last two months
- Have been treated with isotretinoin or other oral retinoids during the last six months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: placebo cream
everyday using of placebo cream
|
using a placebo cream
|
|
Active Comparator: colostrum cream
everyday using of colostrum cream
|
the intervention in our study is everyday using a cream with active ingridient
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
hydration
Time Frame: 8 weeks
|
The skin was measured at standardized temperature and humidity using Courage + Khazaka electronic GmbH Multi Probe Adapter with the use of the aproporate probe. Hydratioan - measurement with corneometer, a capacitance method. The results are shown in in arbitrary units between 0 and 130. 1 CU =0,02 mg water in 1 cm2 epidermal stratum corneum |
8 weeks
|
|
transepidermal water loss
Time Frame: 8 weeks
|
The measurement is taken by Tewameter® TM probe: assessing transepidermal water loss.
The results are shown in g/h/m2
|
8 weeks
|
|
erythema and melanin content
Time Frame: 8 weeks
|
Mexameter® MX18 probe: measuring the level of hemoglobin (erythema) and melanin, the two main dyes responsible for skin color; a broad scale (0-999) of arbitrary Mexameter® units.
The Mexameter ® MX 18 probe emits 3 specific light wavelengths.
A receiver measures the reflection from the skin.
As the quantity of emitted light is defined, the quantity of light absorbed by the skin can be calculated.
|
8 weeks
|
|
sebum
Time Frame: 8 weeks
|
Sebumeter® SM 815 probe: measuring skin sebum level, independent of water content; results are shown as Sebumeter® units from 0-350 (approximated to μg/cm 2 in a certain range)
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
firmness of the skin
Time Frame: 8 weeks
|
The skin was measured at standardized temperature and humidity using Courage + Khazaka electronic GmbH Multi Probe Adapter with the use of the following probe: Cutometer® MPA 580 probe: measuring the viscoelastic properties of the skin. R0 represents the passive response of the skin to force, lower values indicate greater firmness. First max. amplitude, highest point of the curve, this has an implication for the firmness of the skin. Results in mm. Lower values indicate more elastic skin. |
8 weeks
|
|
firmness of the skin
Time Frame: 8 weeks
|
F0 - firmness of the skin at the time of suction.Area dedicated to the firmness of the skin - the skin deformation under the negative pressure - changes in time - mm*s.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- RNN/275/21/KE
- 503/3-066-02/503-31-001 (Other Grant/Funding Number: Medical University of Lodz)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Aging
-
Mert ErsanNot yet recruitingSkin Aging | Skin Quality | Facial Aging
-
Amazentis SAproDERM GmbHCompleted
-
IAS Skin CareCompletedSkin Aging | Transepidermal Water Loss | Skin Hydration | Facial AgingUnited States
-
ChinaNormCompletedMenopause | Skin Aging | Genetic Factors | Reproductive AgingChina
-
AB Biotics, SADr. Goya Análisis, SL.Not yet recruitingSkin | Face Skin Photoaging | Fine Lines | Face Aging/Photo Aging of Moderate Grade | Skin Ageing
-
i+Med S.Coop.Completed
-
i+Med S.Coop.Completed
-
Mesoestetic Pharma Group S.L.CompletedSkin Aging | Skin WrinklingBulgaria
-
Endymion Medical LtdCompletedSkin Aging | Skin WrinklingIsrael
-
Iluminage Ltd.Unknown
Clinical Trials on placebo cream
-
Sixera PharmaCompletedNetherton SyndromeFrance, Sweden, Austria, Germany
-
AstraZenecaFougera Pharmaceuticals Inc.Withdrawn
-
AstraZenecaFougera Pharmaceuticals Inc.Withdrawn
-
University of North Carolina, CharlotteTeva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States
-
Santalis Pharmaceuticals, Inc.ClinDatrix, Inc.; Fremantle DermatologyWithdrawn
-
Dr.dr.Irma Bernadette, SpKK (K)Recruiting
-
Higher School of Applied Sciences (VIST)Abies Labs d.o.o.CompletedSkin Care | Wrinkles | Ageing | Photoprotection | Skin Cream
-
Rock Creek Pharmaceuticals, Inc.CompletedRosaceaUnited States
-
Revotar Biopharmaceuticals AGCompleted
-
Psoriasis Research Institute of GuangzhouRecruitingPsoriasis Vulgaris | Phase III | Topical AdministrationUnited States